| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2012/06/20 | 19 : 05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 19 : 04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 16 : 18 | Dow Jones News | AstraZeneca Completes Acquisition of Ardea Biosciences | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/20 | 05 : 58 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/14 | 06 : 08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/14 | 06 : 03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/13 | 06 : 58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/12 | 03 : 04 | Edgar (US Regulatory) | Schedule 13G | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/09 | 08 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/06 | 03 : 52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/06 | 03 : 51 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/06/05 | 21 : 30 | Marketwired | Ardea Biosciences Announces Expiration of HSR Waiting Period in Connection With Proposed Merger | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/05/31 | 04 : 49 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/05/31 | 02 : 36 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 2012/05/30 | 22 : 05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |